Is Fresenius SE & Co. KGaA (ETR:FRE) Trading At A 45% Discount? [Yahoo! Finance]
FRESENIUS SE S/ADR (FSNUY)
NASDAQ:AMEX Investor Relations:
fresenius.com/index
Company Research
Source: Yahoo! Finance
Current share price of €28.52 suggests Fresenius SE KGaA is potentially 45% undervalued Analyst price target for FRE is €38.63 which is 26% below our fair value estimate In this article we are going to estimate the intrinsic value of Fresenius SE & Co. KGaA (ETR:FRE) by estimating the company's future cash flows and discounting them to their present value. This will be done using the Discounted Cash Flow (DCF) model. It may sound complicated, but actually it is quite simple! We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model See our latest analysis for Fresenius SE KGaA The Method We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growt
Show less
Read more
Impact Snapshot
Event Time:
FSNUY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FSNUY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FSNUY alerts
High impacting FRESENIUS SE S/ADR news events
Weekly update
A roundup of the hottest topics
FSNUY
News
- Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.Business Wire
- Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection, USP [Yahoo! Finance]Yahoo! Finance
- Fresenius Targets Faster Earnings Growth After More Cost Cuts [BNN Bloomberg (Canada)]BNN Bloomberg
- Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections [Yahoo! Finance]Yahoo! Finance